Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 2165462, 10 pages
http://dx.doi.org/10.1155/2016/2165462
Research Article

Mesenchymal Stem Cells Loaded with p5, Derived from CDK5 Activator p35, Inhibit Calcium-Induced CDK5 Activation in Endothelial Cells

1School of Healthcare Science, Manchester Metropolitan University, Manchester, UK
2Department of Neurology, Hospital Universitari Mútua de Terrassa, Terrassa, Barcelona, Spain
3University of Medicine and Pharmacy, Tirgu Mures, Romania
4Department of Medical Laboratories, College of Applied Medical Sciences, Majmaah University, Al Majma’ah, Saudi Arabia
5Griffith University School of Medicine and Queensland Eye Institute, Griffith University, Nathan, QLD, Australia

Received 7 April 2016; Revised 28 June 2016; Accepted 7 August 2016

Academic Editor: Paulo Henrique Rosado de Castro

Copyright © 2016 Wen-Hui Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Slevin and J. Krupinski, “Cyclin-dependent kinase-5 targeting for ischaemic stroke,” Current Opinion in Pharmacology, vol. 9, no. 2, pp. 119–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Smith, W. Neaves, and S. Teitelbaum, “Adult versus embryonic stem cells: treatments,” Science, vol. 316, no. 5830, pp. 1422–1423, 2007. View at Google Scholar · View at Scopus
  3. S. I. Savitz, “Developing cellular therapies for stroke,” Stroke, vol. 46, no. 7, pp. 2026–2031, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Diamandis and C. V. Borlongan, “One, two, three steps toward cell therapy for stroke,” Stroke, vol. 46, no. 2, pp. 588–591, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. T. R. Doeppner and D. M. Hermann, “Editorial: stem cells and progenitor cells in ischemic stroke—fashion or future?” Frontiers in Cellular Neuroscience, vol. 9, no. 2, article 334, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-F. Stoltz, N. de Isla, Y. P. Li et al., “Stem Cells and regenerative medicine: myth or reality of the 21th century,” Stem Cells International, vol. 2015, Article ID 734731, 19 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. G.-I. Kusakawa, T. Saito, R. Onuki, K. Ishiguro, T. Kishimoto, and S.-I. Hisanaga, “Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25,” The Journal of Biological Chemistry, vol. 275, no. 22, pp. 17166–17172, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. M.-S. Lee, Y. T. Kwon, M. Li, J. Peng, R. M. Friedlander, and L.-H. Tsai, “Neurotoxicity induces cleavage of p35 to p25 by calpain,” Nature, vol. 405, no. 6784, pp. 360–364, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. Y.-L. Zheng, C. Li, Y.-F. Hu et al., “Cdk5 Inhibitory Peptide (CIP) inhibits Cdk5/p25 activity induced by high glucose in pancreatic beta cells and recovers insulin secretion from p25 damage,” PLoS ONE, vol. 8, no. 9, article e63332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Kesavapany, Y.-L. Zheng, N. Amin, and H. C. Pant, “Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5,” Biotechnology Journal, vol. 2, no. 8, pp. 978–987, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Zhang, W. Liu, K. K. Szumlinski, and J. Lew, “P10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 49, pp. 20041–20046, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Tan, Y. Chen, J. Li et al., “The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats,” Neuroscience, vol. 290, pp. 552–560, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. B. K. Binukumar, Y.-L. Zheng, V. Shukla, N. D. Amin, P. Grant, and H. C. Pant, “TFP5, a peptide derived from p35, a Cdk5 neuronal activator, rescues cortical neurons from glucose toxicity,” The Journal of Alzheimer's Disease, vol. 39, no. 4, pp. 899–909, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Shukla, Y.-L. Zheng, S. K. Mishra et al., “A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice,” The FASEB Journal, vol. 27, no. 1, pp. 174–186, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-L. Zheng, N. D. Amin, Y.-F. Hu et al., “A 24-residue peptide (p5), derived from p35, the Cdk5 neuronal activator, specifically inhibits Cdk5-p25 hyperactivity and tau hyperphosphorylation,” The Journal of Biological Chemistry, vol. 285, no. 44, pp. 34202–34212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Pacioni, Q. G. D'Alessandris, S. Giannetti et al., “Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts,” Stem Cell Research and Therapy, vol. 6, article 194, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Dossena, G. Bedini, P. Rusmini et al., “Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy,” PLoS ONE, vol. 9, no. 11, Article ID e112746, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Janowski, D. C. Wagner, and J. Boltze, “Stem cell-based tissue replacement after stroke: factual necessity or notorious fiction?” Stroke, vol. 46, no. 8, pp. 2354–2363, 2015. View at Google Scholar
  19. B. Auffinger, R. Morshed, A. Tobias, Y. Cheng, A. U. Ahmed, and M. S. Lesniak, “Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma?” Oncotarget, vol. 4, no. 3, pp. 378–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Sadhukha, T. D. O'Brien, and S. Prabha, “Nano-engineered mesenchymal stem cells as targeted therapeutic carriers,” Journal of Controlled Release, vol. 196, pp. 243–251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. C.-H. Lee, S.-H. Cheng, I.-P. Huang et al., “Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics,” Angewandte Chemie–International Edition, vol. 49, no. 44, pp. 8214–8219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Pascucci, V. Coccè, A. Bonomi et al., “Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery,” Journal of Controlled Release, vol. 192, pp. 262–270, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Huang, F. Zhang, H. Wang et al., “Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery,” Biomaterials, vol. 34, no. 7, pp. 1772–1780, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Rashidian, G. Iyirhiaro, H. Aleyasin et al., “Multiple cyclin-dependent kinases signals are critical mediators of ischemia/hypoxic neuronal death in vitro and in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 14080–14085, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. J.-H. Lee, H.-S. Kim, S.-J. Lee, and K.-T. Kim, “Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death,” Journal of Cell Science, vol. 120, no. 13, pp. 2259–2271, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. E. Contreras-Vallejos, E. Utreras, and C. Gonzalez-Billault, “Going out of the brain: non-nervous system physiological and pathological functions of Cdk5,” Cellular Signalling, vol. 24, no. 1, pp. 44–52, 2012. View at Publisher · View at Google Scholar · View at Scopus